Genetic Diagnosis of hereditary cardiomyopathies
Genetic diagnosis is one of the most important instruments in the clinical management of patients with inherited cardiovascular disease today. European and national guidelines recommend genetic testing for patients with cardiomyopathies, channelopathies, diseases of the aorta, hyperlipidemia and sudden cardiac death.
The IKDT lab, as an international market leader in the diagnosis of cardiomyopathy, is now offering its customers the most complete and advanced genetic testing for all major genetically related forms of cardiomyopathies. Through the cooperation with our Spanish partners Health-in-Code we can not only deliver the best quality in the genetic analysis, but also the most comprehensive clinically oriented information on the mutations identified by the applied technology of next-generation sequencing. This relates not only to the classic genetic forms (ARVD, HCM, Long QT, short QT), the genetic testing for Fabry disease, and hereditary forms of amyloidosis.
With our approach, our submitter receive the maximum possible diagnostic value for their patients and can then take the necessary medical steps in the way.